Smaller Drug Makers Chugai, Mitsubishi Tanabe Less Exposed To Bad Economy Than Big
This article was originally published in PharmAsia News
Executive Summary
Smaller Japanese drug makers have done a better job surviving the global economic crisis than have their larger competitors. Among the second-tier Japanese pharmaceuticals doing well in a troubled period are Chugai Pharmaceutical, Mitsubishi Tanabe Pharma and Tsumura, primarily because they are less exposed to economic conditions in other nations such as the United States. The small and midsize firms also have spent less than the larger ones on acquisitions in recent years that made them more exposed to a market downturn. (Click here for more - a subscription may be required